Xpovio (selinexor) is a prescription medicine with a specific indication for treating certain types of cancer.
Xpovio Indication Explained
According to the provided reference, Xpovio is approved for the following indication:
- Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL): Xpovio is used for adult patients with DLBCL (not otherwise specified, including DLBCL arising from follicular lymphoma) after at least two prior lines of systemic therapy.
In simpler terms, Xpovio is used to treat a specific type of lymphoma called Diffuse Large B-Cell Lymphoma (DLBCL) when it has either returned after previous treatment (relapsed) or has not responded to previous treatment (refractory), and only after the patient has tried at least two other treatment options.
